Accelerating Medicines Partnership® SCHIZOPHRENIA
News and Updates
Keep up with the latest news about the Accelerating Medicines Partnership (AMP®) SCZ program.

Recruitment Updates

March 14, 2023: 356 individuals have been consented across 29 sites into the AMP SCZ study. Of these participants, 212 completed screening and are in baseline or months 1 – 7.

Last Reviewed on March 14, 2023